Perinatal HIV transmission substantially contributes to infant and child morbidity and mortality in sub- Saharan Africa. In Malawi, the prevalence of HIV is about 30% among pregnant women and the infant mortality is more than 100 per 1000 live births. Use of antiretroviral drugs has substantially reduced HIV mother to child transmission (MTCT). For example, in the U.S. use of a full (during pregnancy, intrapartum and postpartum) regimen of zidovudine (ZDV) reduced MTCT of HIV by 67%, and in Thailand a shorter (during late pregnancy and intrapartum) regimen of ZDV therapy reduced perinatal HIV transmission by 50%. A more practical and less expensive regimen on nevirapine (NVP) intrapartum to the mother and to the neonate reduced MTCT of HIV by about 50% in a breastfeeding population in Uganda (HIVNET 012). However, some barriers such as counseling and testing need to be overcome to widely implement even this simple regimen of oral NVP. Not all women attend the antenatal clinic, they arrive late to the labor room for delivery, and they do not know their HIV status. Therefore, there is no adequate time to counsel and test women prior to delivery to administer NVP at onset of labor. The purpose of the proposed AIDS-FIRCA study is to determine in a traditionally breast-feeding community in Malawi if a short prophylactic regimen of oral NVP and ZDV given directly to the baby at time of birth reduces the rate of MTCT of HIV. In this randomized clinical trial women who consent to join the study based on their attendance to the labor room (early or late presenters) will receive intrapartum NVP. Their babies will received oral NVP and will be randomized to receive or not receive ZDV for a week. MTCT of HIV will be estimated at birth, 6 weeks, 12 months and to 24 months. These analyses will determine if this simple regimen reduces MTCT of HIV at these time points. The results of this study could have major policy implications. Adequate research infrastructure is available on site to support this study. ? ?

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
Small Research Grants (R03)
Project #
5R03TW001199-05
Application #
6665189
Study Section
AIDS and Related Research 8 (AARR)
Program Officer
Mcdermott, Jeanne
Project Start
1999-09-30
Project End
2005-08-31
Budget Start
2003-09-01
Budget End
2004-08-31
Support Year
5
Fiscal Year
2003
Total Cost
$40,000
Indirect Cost
Name
Johns Hopkins University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Taha, Taha E; Dadabhai, Sufia S; Sun, Jin et al. (2012) Child mortality levels and trends by HIV status in Blantyre, Malawi: 1989-2009. J Acquir Immune Defic Syndr 61:226-34
Taha, Taha E; Dadabhai, Sufia S; Rahman, M Hafizur et al. (2012) Trends in birth weight and gestational age for infants born to HIV-infected, antiretroviral treatment-naive women in Malawi. Pediatr Infect Dis J 31:481-6
Kafulafula, George; Hoover, Donald R; Taha, Taha E et al. (2010) Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi. J Acquir Immune Defic Syndr 53:6-13
Taha, Taha; Nour, Samah; Li, Qing et al. (2010) The effect of human immunodeficiency virus and breastfeeding on the nutritional status of African children. Pediatr Infect Dis J 29:514-8
Church, Jessica D; Towler, William I; Hoover, Donald R et al. (2008) Comparison of LigAmp and an ASPCR assay for detection and quantification of K103N-containing HIV variants. AIDS Res Hum Retroviruses 24:595-605
Gulia, Jyoti; Kumwenda, Newton; Li, Qing et al. (2007) HIV seroreversion time in HIV-1-uninfected children born to HIV-1-infected mothers in Malawi. J Acquir Immune Defic Syndr 46:332-7
Church, Jessica D; Hudelson, Sarah E; Guay, Laura A et al. (2007) HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D. AIDS Res Hum Retroviruses 23:764-8
Taha, Taha E; Hoover, Donald R; Kumwenda, Newton I et al. (2007) Late postnatal transmission of HIV-1 and associated factors. J Infect Dis 196:10-4
Flys, Tamara S; Chen, Shu; Jones, Dana C et al. (2006) Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D. J Acquir Immune Defic Syndr 42:610-3
Eshleman, Susan H; Hoover, Donald R; Hudelson, Sarah E et al. (2006) Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1. J Infect Dis 193:479-81

Showing the most recent 10 out of 17 publications